← Research & Industry News
External source
Rational design of lipid nanoparticles for brain delivery of RNA therapeutics
Lipid nanoparticles modified with hydroxyzine, an antihistamine compound active in the central nervous system, enable brain delivery of mRNA and gene-editing components in multiple animal models.
- Published by
- Nature Nanotechnology
- Evidence type
- Laboratory
Lipid nanoparticles modified with hydroxyzine, an antihistamine compound active in the central nervous system, enable brain delivery of mRNA and gene-editing components in multiple animal models.
This item was selected automatically by our daily literature and news monitor because it matches the topics we follow. Read the full story at Nature Nanotechnology.
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.
ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.